Side effects will be discussed during the initial consultation and you may need approval from your primary care physician
This phenomenon is further illustrated by results from a randomized, open-label mechanistic trial in patients with T2DM, which demonstrated that lixisenatide, with a half-life of 2 4 hours, had a significantly greater effect than liraglutide in delaying in gastric emptying and curtailing postprandial glucose excursions following a standardized solid breakfast (156)
Most patients tolerate provider-guided peptide therapy well when used under medical supervision
A long-term, randomised, double-blind, placebo-controlled study
You can also use a smartphone or web app to monitor your daily food intake, weight, exercise levels, and other factors